BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32498134)

  • 1. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
    Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
    Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.
    Alves-Bezerra M; Li Y; Acuña M; Ivanova AA; Corey KE; Ortlund EA; Cohen DE
    Hepatology; 2019 Aug; 70(2):496-510. PubMed ID: 30516845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyl-CoA thioesterase 9 (ACOT9) in mouse may provide a novel link between fatty acid and amino acid metabolism in mitochondria.
    Tillander V; Arvidsson Nordström E; Reilly J; Strozyk M; Van Veldhoven PP; Hunt MC; Alexson SE
    Cell Mol Life Sci; 2014 Mar; 71(5):933-48. PubMed ID: 23864032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-CoA thioesterase 9 promotes tumour growth and metastasis through reprogramming of fatty acid metabolism in hepatocellular carcinoma.
    Wang B; Zhang H; Chen YF; Hu LQ; Tian YY; Tong HW; Wang G; Chen C; Yuan P
    Liver Int; 2022 Nov; 42(11):2548-2561. PubMed ID: 36004563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mitochondrial thioesterases have distinct tissue and substrate specificity and CoA regulation, suggesting unique functional roles.
    Bekeova C; Anderson-Pullinger L; Boye K; Boos F; Sharpadskaya Y; Herrmann JM; Seifert EL
    J Biol Chem; 2019 Dec; 294(50):19034-19047. PubMed ID: 31676684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver.
    Moffat C; Bhatia L; Nguyen T; Lynch P; Wang M; Wang D; Ilkayeva OR; Han X; Hirschey MD; Claypool SM; Seifert EL
    J Lipid Res; 2014 Dec; 55(12):2458-70. PubMed ID: 25114170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism.
    Hunt MC; Solaas K; Kase BF; Alexson SE
    J Biol Chem; 2002 Jan; 277(2):1128-38. PubMed ID: 11673457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism.
    Kang HW; Niepel MW; Han S; Kawano Y; Cohen DE
    FASEB J; 2012 May; 26(5):2209-21. PubMed ID: 22345407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioesterase superfamily member 2/Acyl-CoA thioesterase 13 (Them2/Acot13) regulates adaptive thermogenesis in mice.
    Kang HW; Ozdemir C; Kawano Y; LeClair KB; Vernochet C; Kahn CR; Hagen SJ; Cohen DE
    J Biol Chem; 2013 Nov; 288(46):33376-86. PubMed ID: 24072708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioesterase superfamily member 2 (Them2) and phosphatidylcholine transfer protein (PC-TP) interact to promote fatty acid oxidation and control glucose utilization.
    Kawano Y; Ersoy BA; Li Y; Nishiumi S; Yoshida M; Cohen DE
    Mol Cell Biol; 2014 Jul; 34(13):2396-408. PubMed ID: 24732803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of thioesterase superfamily member 2 in skeletal muscle promotes hepatic steatosis and insulin resistance in mice.
    Imai N; Nicholls HT; Alves-Bezerra M; Li Y; Ivanova AA; Ortlund EA; Cohen DE
    Hepatology; 2022 Jan; 75(1):154-169. PubMed ID: 34433228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs.
    Hammond LE; Neschen S; Romanelli AJ; Cline GW; Ilkayeva OR; Shulman GI; Muoio DM; Coleman RA
    J Biol Chem; 2005 Jul; 280(27):25629-36. PubMed ID: 15878874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.
    Koo SH
    Clin Mol Hepatol; 2013 Sep; 19(3):210-5. PubMed ID: 24133660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.
    Cotter DG; Ercal B; Huang X; Leid JM; d'Avignon DA; Graham MJ; Dietzen DJ; Brunt EM; Patti GJ; Crawford PA
    J Clin Invest; 2014 Dec; 124(12):5175-90. PubMed ID: 25347470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice.
    Devereux CJ; Bayliss J; Keenan SN; Montgomery MK; Watt MJ
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E187-E198. PubMed ID: 36629823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.